Proteomic Profiling of Serum Exosomes From Patients With Metastatic Gastric Cancer

Abstract

Background: Clinical management of metastatic gastric cancer (mGC) remains a major challenge due to a lack of specific biomarkers and effective therapeutic targets. Recently, accumulating evidence has suggested that exosomes play an essential role in cancer metastasis and can be an excellent reservoir of novel biomarkers and candidate therapeutic targets for cancer. Therefore, in this study, we aimed to reveal the proteomic profile of mGC-derived exosomes. Methods: Exosomes were isolated from pooled serum samples of 20 mGC patients and 40 healthy controls (HC) by ultracentrifugation. Next, quantitative proteomic analyses were applied to analyze the protein profiles of the exosomes, and bioinformatic analyses were conducted on the proteomic data. Finally, the expression of exosomal protein candidates was selectively validated in individual subjects by western blot analysis. Results: We isolated exosomes from serum samples. The size of the serum derived exosomes ranged from 30 to 150 nm in diameter. The exosomal markers CD9 and CD81 were observed in the serum exosomes. However, the exosomal negative marker calnexin, an endoplasmic reticulum protein, was not detected in exosomes. Overall, 443 exosomal proteins, including 110 differentially expressed proteins (DEPs) were identified by quantitative proteomics analyses. The bioinformatics analyses indicated that the upregulated proteins were enriched in the process of protein metabolic, whereas the downregulated proteins were largely involved in cell-cell adhesion organization. Surprisingly, 10 highly vital proteins (UBA52,

Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma

“…Proteasome 20S subunit alpha (PSMA) 3, PSMA4 , PSMA5 , tripartite motif containing 9 (TRIM9), and GTP cyclohydrolase 1(GCH1) were the top 5 hub genes. PSMA is a proteasome subunit alpha type associated with the occurrence and development of multiple cancers [ 14 , 15 ].…”

The Emerging Role of Liquid Biopsy in Gastric Cancer

“…Liquid biopsies may also help diagnose resistance to treatment before radiological progression and are gaining more relevance as a tool for optimizing patient care. The serum exosome proteome of metastatic gastric cancer patients was defined recently in detail by Ding et al [ 75 ]. A study showed that, in gastric cell lines, exosomal Ribosomal Protein S3 (RPS3) secreted by cisplatin-resistant tumor cells could be taken up by cisplatin-sensitive cells and thus become chemoresistant (through activation of the PI3K-Akt-cofilin-1 signaling pathway) [ 76 ].…”

The role and application of small extracellular vesicles in gastric cancer

“…The AUC of this meaningful study was 0.923, and this approach is expected to become a highly accurate method for detecting early GC. For patients with metastatic GC, Ding et al [ 169 ] provided a comprehensive description of the serum sEVs-proteome and found that several subunits might act as biomarkers and therapeutic targets.…”